Cargando…
Dual Glycation-Inflammation Modulation, DPP-IV and Pancraetic Lipase Inhibitory Potentials and Antiproliferative Activity of Novel Fluoroquinolones
Paramount efforts by pharmaceutical industry to identify new targets for obesity-diabetes (Diabesity) pharmacological intervention have led to a number of agents developed and directed at DPP IV [dipeptidyl peptidase IV] enzyme inhibition thereby enhancing endogenous insulinotropic incretins. Beside...
Autores principales: | Arabiyat, Shereen, Kasabri, Violet, Al-Hiari, Yusuf, AL-MASRI, Ihab, Alalawi, Sundus, Bustanji, Yasser K |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
West Asia Organization for Cancer Prevention
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6852796/ https://www.ncbi.nlm.nih.gov/pubmed/31450926 http://dx.doi.org/10.31557/APJCP.2019.20.8.2503 |
Ejemplares similares
-
Selected Statins as Dual Antiproliferative-Antiinflammatory Compounds
por: Hussein, Buchra Haj, et al.
Publicado: (2022) -
A Novel Class of Functionalized Synthetic Fluoroquinolones with Dual Antiproliferative - Antimicrobial Capacities
por: Al-Nuaimi, Abdelrahman, et al.
Publicado: (2021) -
Antiproliferative Activities of Lipophililic Fluoroquinolones-Based Scaffold Against a Panel of Solid and Liquid Cancer Cell Lines
por: Qashou, Esraa, et al.
Publicado: (2022) -
Newly Substituted Anilino-Fluoroquinolones with Proliferation Inhibition Potential against a Panel of Cancer Cell Lines
por: Salih, Mohammed Ameen Fouad, et al.
Publicado: (2022) -
Vanillic Acid Inhibited the Induced Glycation Using In Vitro and In Vivo Models
por: Alhadid, Amani, et al.
Publicado: (2022)